Cargando…
Intestinal TG3- and TG2-Specific Plasma Cell Responses in Dermatitis Herpetiformis Patients Undergoing a Gluten Challenge
Dermatitis herpetiformis (DH), a cutaneous manifestation of coeliac disease, is characterized by transglutaminase (TG) 3-targeted dermal immunoglobulin A (IgA) deposits. The treatment for DH is the same as for coeliac disease, namely a life-long gluten-free diet. DH patients typically have gluten-de...
Autores principales: | Sankari, Hanna, Hietikko, Minna, Kurppa, Kalle, Kaukinen, Katri, Mansikka, Eriika, Huhtala, Heini, Laurila, Kaija, Reunala, Timo, Hervonen, Kaisa, Salmi, Teea, Lindfors, Katri |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7071213/ https://www.ncbi.nlm.nih.gov/pubmed/32069794 http://dx.doi.org/10.3390/nu12020467 |
Ejemplares similares
-
Prognosis of Dermatitis Herpetiformis Patients with and without Villous Atrophy at Diagnosis
por: Mansikka, Eriika, et al.
Publicado: (2018) -
The Long-Term Safety and Quality of Life Effects of Oats in Dermatitis Herpetiformis
por: Alakoski, Anna, et al.
Publicado: (2020) -
Small-intestinal TG2-specific plasma cells at different stages of coeliac disease
por: Hietikko, Minna, et al.
Publicado: (2018) -
Sex-differences in Gluten-free Dietary Adherence and Clinical Symptoms in Patients with Long-term Treated Dermatitis Herpetiformis
por: PASTERNACK, Camilla, et al.
Publicado: (2022) -
Persistent Skin Symptoms after Diagnosis and on a Long-term Gluten-free Diet in Dermatitis Herpetiformis
por: PASTERNACK, Camilla, et al.
Publicado: (2021)